| First Author | Tamminen T | Year | 2021 |
| Journal | Oxid Med Cell Longev | Volume | 2021 |
| Pages | 8028427 | PubMed ID | 34917233 |
| Mgi Jnum | J:324804 | Mgi Id | MGI:6836483 |
| Doi | 10.1155/2021/8028427 | Citation | Tamminen T, et al. (2021) Pinosylvin Extract Retinari Sustains Electrophysiological Function, Prevents Thinning of Retina, and Enhances Cellular Response to Oxidative Stress in NFE2L2 Knockout Mice. Oxid Med Cell Longev 2021:8028427 |
| abstractText | Chronic oxidative stress eventually leads to protein aggregation in combination with impaired autophagy, which has been observed in age-related macular degeneration. We have previously shown an effective age-related macular degeneration disease model in mice with nuclear factor-erythroid 2-related factor-2 (NFE2L2) knockout. We have also shown pinosylvin, a polyphenol abundant in bark waste, to increase human retinal pigment epithelium cell viability in vitro. In this work, the effects of commercial natural pinosylvin extract, Retinari, were studied on the electroretinogram, optical coherence tomogram, autophagic activity, antioxidant capacity, and inflammation markers. Wild-type and NFE2L2 knockout mice were raised until the age of 14.8 +/- 3.8 months. They were fed with either regular or Retinari chow (141 +/- 17.0 mg/kg/day of pinosylvin) for 10 weeks before the assays. Retinari treatment preserved significant retinal function with significantly preserved a- and b-wave amplitudes in the electroretinogram responses. Additionally, the treatment prevented thinning of the retina in the NFE2L2 knockout mice. The NFE2L2 knockout mice showed reduced ubiquitin-tagged protein accumulation in addition to local upregulation of complement factor H and antioxidant enzymes superoxide dismutase 1 and catalase. Therefore, the treatment in the NFE2L2 KO disease model led to reduced chronic oxidative stress and sustained retinal function and morphology. Our results demonstrate that pinosylvin supplementation could potentially lower the risk of age-related macular degeneration onset and slow down its progression. |
